Inovio Pharmaceuticals Accelerates Timeline for Its Coronavirus Vaccine, Shares Jump 70%

Inovio Pharmaceuticals (NASDAQ: INO) is making progress in its efforts to develop a vaccine for SARS-CoV-2, the coronavirus that causes COVID-19. Shares of the biotech company closed up 70% on Tuesday on word that it could start a clinical trial next month.